Welcome to our dedicated page for So-Young International American Depository Shares news (Ticker: SY), a resource for investors and traders seeking the latest updates and insights on So-Young International American Depository Shares stock.
So-Young International Inc. (symbol: SY) operates a leading online platform for medical aesthetics and elective healthcare services. Established in China, the company focuses on providing users with reliable information about medical aesthetic procedures. Through its platform, users can discover content, share personal experiences, and reserve treatment services from vetted medical aesthetic providers. This service is available not only in China but also internationally.
So-Young's business model includes four key components: distribution of professional content via social media and targeted media platforms, a vibrant social community rich in user-generated content, online reservation services for medical aesthetic treatments, and the research, development, and sales of medical beauty equipment. The company generates revenue through information service fees and reservation fees from its network of approximately 6,100 medical aesthetic service providers.
In addition to aesthetical treatments, So-Young facilitates user reservations for a broad range of medical services, including dermatology, dentistry, ophthalmology, gynecology, HPV vaccinations, and postnatal care.
Recent achievements include several strategic developments and new partnerships. For instance, in November 2023, So-Young reported strong financial results with a 19.2% increase in total revenues year-over-year to RMB385.3 million. In December 2023, the company announced a significant partnership with Healtech to develop regenerative medical aesthetic products, marking a major step in expanding their supply chain business.
Additionally, the leadership team has undergone recent changes to bolster expertise and drive growth. As of October 2023, the board appointed Ms. Nan Shen, a seasoned financial expert, as an independent director. This appointment aligns with So-Young's commitment to reinforcing internal growth and maintaining high standards of governance.
Financially, So-Young has demonstrated resilience despite macroeconomic challenges, achieving a net income of RMB18.3 million in the third quarter of 2023. The company maintains a strong cash position with RMB1,405.4 million in cash, cash equivalents, restricted cash, and short-term investments as of September 30, 2023.
Leveraging its strong brand image, extensive audience reach, and rich data insights, So-Young is well-positioned to expand both within the medical aesthetic industry and the broader consumption healthcare market. For investors, So-Young continues to stand out as a promising player in the fast-growing medical aesthetics sector.
So-Young International Inc. (NASDAQ: SY) will report its financial results for the second quarter ended June 30, 2022, before U.S. markets open on August 16, 2022. An earnings conference call will follow on the same day at 7:30 AM U.S. Eastern Time. Due to COVID-19, participants must preregister online to receive dial-in details. So-Young is a leading platform in China's medical aesthetics industry, providing trusted information and community engagement for consumers and service providers.
So-Young International Inc. (Nasdaq: SY) announced it received a notification from Nasdaq regarding non-compliance with minimum bid price requirements, as its ADSs closed below $1.00 for 30 consecutive days. The company has until January 11, 2023, to regain compliance. If the ADS price reaches $1.00 for at least ten consecutive business days, Nasdaq will confirm compliance. The notification does not affect business operations, and So-Young plans to take measures to regain compliance within the grace period.
So-Young International (SY) reported unaudited financial results for Q1 2022, with total revenues of RMB300.3 million, down 16.5% year-over-year. The net loss widened to RMB66.8 million from RMB45.0 million in Q1 2021. Average monthly active users decreased significantly to 4.4 million from 8.4 million. Despite challenges from COVID-19, the company saw a 11.7% increase in paying medical service providers, totaling 5,254. The decline in revenue stemmed largely from reduced average revenue per provider, prompting a cautious outlook with no revenue guidance for Q2 2022 amid ongoing uncertainties.
So-Young International Inc. (NASDAQ: SY) will report its financial results for the first quarter ending March 31, 2022, on May 23, 2022, before U.S. markets open. As the largest social community in China focused on medical aesthetics, So-Young connects consumers and service providers, driving engagement and trust within the sector. The earnings release will be available on the Company's investor relations webpage, highlighting its position to expand in both medical aesthetics and the broader healthcare service market.
So-Young International Inc. (Nasdaq: SY) announced updates regarding its status under the Holding Foreign Companies Accountable Act (HFCAA) after being identified by the SEC on May 9, 2022. The identification stems from the use of a public accounting firm whose working papers cannot be fully inspected by the PCAOB for the fiscal year ending December 31, 2021. If identified for three consecutive years, So-Young's shares could be prohibited from trading in the U.S. The Company is actively seeking solutions to protect stakeholder interests and intends to comply with all applicable regulations to maintain its Nasdaq listing.
So-Young International Inc. (Nasdaq: SY), a leading social community in China's medical aesthetics sector, has filed its annual report on Form 20-F for the fiscal year ending December 31, 2021, with the SEC on May 2, 2022. The report is accessible on the Company's investor relations website. Shareholders can request a hard copy of the report, including audited financial statements, at no charge. So-Young aims to leverage its brand and user trust to expand in the medical aesthetics industry and the broader healthcare market.
So-Young International Inc. (SY) reported its fourth quarter and fiscal year 2021 financial results. Total revenues for Q4 reached RMB449.5 million (US$70.5 million), a 5.9% increase year-over-year. However, the company experienced a net loss of RMB27.7 million (US$4.4 million) compared to a profit of RMB38.6 million in Q4 2020. For the full year, revenues grew 30.7% to RMB1,692.5 million (US$265.6 million), but net loss was RMB8.4 million (US$1.3 million) against a profit in FY 2020. The company anticipates Q1 2022 revenues to decrease by 16.6% to 19.4% due to ongoing market uncertainties.
So-Young International Inc. (NASDAQ: SY) will release its financial results for Q4 and the full year ended December 31, 2021, on March 25, 2022, before U.S. markets open. The company is the leading social community in China's medical aesthetics sector, offering trustworthy content and a platform that connects consumers with vetted service providers. With a strong brand image and engaging community, So-Young aims to expand in both the medical aesthetics and fast-growing healthcare service markets.
So-Young International Inc. (Nasdaq: SY) announced that its board's special committee has engaged Duff & Phelps and Gibson, Dunn & Crutcher LLP to evaluate a non-binding proposal from CEO Xing Jin. The offer proposes to acquire all outstanding Class A shares not already owned by him for $5.30 per American Depositary Share (ADS). The company cautions that this proposal is preliminary, with no binding commitments made yet, and no decisions have been reached regarding the transaction. Shareholders are advised that no action is required at this time.
So-Young International Inc. (Nasdaq: SY) announced a non-binding proposal from CEO Xing Jin to acquire all outstanding Class A ordinary shares not owned by him for $5.30 per ADS or $6.89 per share in cash. This represents a premium of approximately 22.7% over the closing price on November 19, 2021. The company's board has formed a special committee of independent directors to evaluate the proposal, with no decisions made at this stage. There is no assurance that the acquisition will proceed, as it hinges on further negotiations and definitive agreements.
FAQ
What is the current stock price of So-Young International American Depository Shares (SY)?
What is the market cap of So-Young International American Depository Shares (SY)?
What does So-Young International Inc. do?
Where are So-Young's services available?
What are So-Young’s main revenue sources?
Who are So-Young's partners?
What recent financial achievements has So-Young reported?
What services does So-Young offer beyond medical aesthetics?
What recent leadership changes have occurred at So-Young?
What strategic developments has So-Young undertaken recently?
How does So-Young ensure the quality of its service providers?